Figure 1 Kaplan-Meier curves of recurrence-free survival (Panel
A) and breast cancer-related death (Panel B) of 404 patients
with stage I, II and III breast cancer. Patients were divided into
those with 0 circulating tumor cells (CTC) detected in 30 ml of
blood and those with 1 or more CTC in 30 ml of blood